Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 9.15
-0.10 (-1.06%)
At close: Mar 18, 2026
Grifols Market Cap
Grifols has a market cap or net worth of €5.64 billion as of March 18, 2026. Its market cap has decreased by -8.46% in one year.
Market Cap
5.64B
Enterprise Value
16.77B
Revenue
7.52B
Ranking
n/a
PE Ratio
15.52
Stock Price
€9.15
Market Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 5.64B, an increase of 673.87%. That is a compound annual growth rate of 10.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 5.64B | -13.71% |
| Dec 31, 2025 | 6.54B | 15.08% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 4.09B |
| Almirall | 2.47B |
| Pharma Mar | 1.50B |
| Faes Farma | 1.40B |
| Clínica Baviera | 804.13M |
| Atrys Health | 223.07M |
| Oryzon Genomics | 221.69M |
| Prim, S.A. | 217.80M |